In Parliament

The Department of Health and Social Care has indicated that it will not be possible to answer this question within the usual time period.

Diabetic eye screening has continued through the pandemic response for those at highest risk.

The Department along with NHS England and NHS Improvement and Public Health England (PHE) are currently planning for the delivery of a succe

Enzyme replacement therapy for CLN2 (Batten disease) is available through a managed access agreement.

The Government is committed to improving the lives of those affected by rare diseases such as Batten disease.

The Department, in consultation with the devolved administrations and Crown Dependencies, is working with trade bodies, product suppliers, a

The patient registry for cannabis-based products for medicinal use is currently being developed by NHS England and NHS Improvement with inpu

The NHS Business Services Authority is unable to provide the number of National Health Service prescription items for unlicensed cannabis-ba

We are informed by the National Institute for Health and Care Excellence (NICE) that its methods review is proceeding apace, and NICE is bei

The 2019 Voluntary Scheme for Branded Medicines Pricing and Access set out a range of measures to support innovation and improve patient out